Fig. S1. Cisplatin resistance of TAP and TAP-YB-1 clones.

Fig. S2. Depletion of PABPC1, MRPS7, and RB1CC1 with specific siRNA molecules in MCF7 cells.

Fig. S3. Response of transfected MCF7 cells to cisplatin.

Fig. S4. Response of transfected MDA-MB-231 cells to cisplatin.

Fig. S5. Examples of FACS cell cycle analysis of MDA-MB-231 cells transfected with an empty vector (left) and a YB-1 expression vector (right).

Table S1. List of proteins potentially interacting with YB-1, their chromosomal localization, and expression levels in breast cancer.

Table S2. Sequence of each siRNA used to establish dose–response curves.

Data S1.Materials and methods.

CAS_1948_sm_fS1.jpg200KSupporting info item
CAS_1948_sm_fS2.jpg777KSupporting info item
CAS_1948_sm_fS3.jpg1021KSupporting info item
CAS_1948_sm_fS4.jpg1063KSupporting info item
CAS_1948_sm_fS5.jpg761KSupporting info item
CAS_1948_sm_tS1.xls32KSupporting info item
CAS_1948_sm_tS2.xls22KSupporting info item
CAS_1948_sm_DataS1.doc44KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.